Gilead Sciences | 판매 매출 총 이익

Gross Profit On Sales 변화 날짜
AbbVie USD 8.22B 1.35B 2024-03
Agios Pharmaceuticals USD 7.56M 1.04M 2024-03
ALKERMES USD 291.73M 15.62M 2024-03
Alnylam Pharmaceuticals USD 428.36M 74.5M 2024-03
Amgen USD 4.25B 837M 2024-03
Biogen USD 1.75B 19.7M 2024-03
BioMarin Pharmaceutical USD 523.65M 12.92M 2024-03
Bristol-Myers Squibb USD 8.93B 163M 2024-03
Eli Lilly USD 7.09B 470.9M 2024-03
Gilead Sciences USD 5.13B 370M 2024-03
GlaxoSmithKline GBP 5.39B 326M 2024-03
Glaxosmithkline GBP 5.39B 326M 2024-03
Incyte USD 819.89M 129.4M 2024-03
J&J USD 14.87B 275M 2024-03
Merck USD 12.24B 945M 2024-03
Moderna USD 71M 1.81B 2024-03
Neurocrine Biosciences USD 507.8M 20.2M 2024-03
Novartis USD 9.02B 235M 2024-03
Pfizer USD 11.5B 3.92B 2024-03
PTC Therapeutics USD 195.38M 82.56M 2024-03
Regeneron Pharmaceuticals USD 2.71B 206.1M 2024-03
Sanofi EUR 7.68B 1.18B 2024-03
Sarepta Therapeutics USD 362.9M 68.11M 2024-03
United Therapeutics USD 604.8M 61.1M 2024-03
Vertex Pharmaceuticals USD 2.35B 183.2M 2024-03



Gilead Sciences 판매 매출 총 이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - Jun 2024.